BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 184086)

  • 1. Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics.
    Pichard AL; Cheung WY
    J Biol Chem; 1976 Sep; 251(18):5726-37. PubMed ID: 184086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S; Menon KM
    Eur J Biochem; 1977 Feb; 73(1):73-82. PubMed ID: 190011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3':5'-cyclic-nucleotide phosphodiesterases of mammalian sera.
    Asano T; Hidaka H
    Biochim Biophys Acta; 1975 Jul; 397(1):124-33. PubMed ID: 238629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
    Iwase K
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
    Craven PA; Neidig M; DeRubertis FR
    Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3',5' Cyclic nucleotide phosphodiesterase from human platelets: effect of heat upon the multiple forms and their interconversion.
    Pichard AL; Choury D; Kaplan JC
    Biochimie; 1981 Jul; 63(7):603-9. PubMed ID: 6269658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterases in uterine development.
    Stancel GM; Thompson WJ; Strada SJ
    Mol Cell Endocrinol; 1975 Oct; 3(4):283-95. PubMed ID: 172392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of nucleoside cyclic 3':5'-monophosphate phosphodiesterase activity from rat brain by a modulator and Ca2+.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3526-30. PubMed ID: 4357877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood.
    Patterson WD; Hardman JG; Sutherland EW
    Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
    Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
    Gardner EA; Thompson WJ; Strada SJ; Stancel GM
    Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterase activities of the fetal and mature human cerebral cortex.
    Kang ES
    Pediatr Res; 1977 May; 11(5):655-63. PubMed ID: 193085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.